Gaas, Marcial G.
HRN: 19-12-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/14/2025
10/20/2025
IV
1.5
Q8
Gouty Arthritis In Flare
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes